Western Pacific Wealth Management’s GSK GSK Stock Holding History

Western Pacific Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-79	Closed	-$3.23K	–	235
2024 Q3	$3.23K	Buy	79 +1	+1%	+$41	﹤0.01%	226
2024 Q2	$3.01K	Buy	78 +1	+1%	+$42	﹤0.01%	202
2024 Q1	$3.32K	Hold	77	–	–	﹤0.01%	226
2023 Q4	$2.84K	Buy	77 +1	+1%	+$36	﹤0.01%	215
2023 Q3	$2.75K	Hold	76	–	–	﹤0.01%	241
2023 Q2	$2.71K	Hold	76	–	–	﹤0.01%	249
2023 Q1	$2.7K	Hold	76	–	–	﹤0.01%	262
2022 Q4	$2.67K	Hold	76	–	–	﹤0.01%	258
2022 Q3	$2K	Hold	76	–	–	﹤0.01%	221
2022 Q2	$4K	Hold	76	–	–	﹤0.01%	160
2022 Q1	$4K	Hold	76	–	–	﹤0.01%	183
2021 Q4	$4K	Buy	+76	New	+$3.95K	﹤0.01%	182

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Western Pacific Wealth Management's GSK Position: Q4 2024 in Review

Western Pacific Wealth Management sold out of GSK (GSK) in Q4 2024, closing a stake of 79 shares — an estimated $3.23K sold.

Western Pacific Wealth Management first reported a position in GSK in Q4 2021 and held it in 12 quarters. The position peaked at $4K in Q2 2022. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Western Pacific Wealth Management reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Western Pacific Wealth Management sold 79 GSK shares in Q4 2024, an estimated $3.23K.
Western Pacific Wealth Management first reported a position in GSK in Q4 2021 and held it in 12 quarters.
Western Pacific Wealth Management's GSK position peaked at $4K in Q2 2022.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Western Pacific Wealth Management's 13F filing for Q4 2024, filed 24 Jan 2025.